What is the role of dendritic cells (DCs) in the immune system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Role of Dendritic Cells in the Immune System

Dendritic cells (DCs) serve as the master regulators of the immune response by acting as the critical bridge between innate and adaptive immunity, capturing antigens at epithelial barriers, migrating to lymph nodes, and orchestrating T cell responses through antigen presentation and cytokine signaling. 1

Primary Functions of Dendritic Cells

Antigen Capture and Surveillance

  • DCs position themselves underneath epithelial barriers as professional antigen-presenting cells, waiting to capture foreign entities using their dendrites, which can extend through the epithelial barrier to sense the external environment. 1

  • DCs utilize specialized surface receptors for antigen uptake, including endocytosis receptors, phagocytosis receptors, and C-type lectin receptors, enabling efficient capture of pathogens and foreign materials. 2

  • DCs employ various pattern recognition receptors (including Toll-like receptors) to monitor their local environment for danger signals to the body, allowing them to distinguish between harmless antigens and genuine threats. 1, 2

Bridge Between Innate and Adaptive Immunity

  • Upon activation by danger signals, DCs migrate to lymph nodes where they interact with T cells through antigen-specific signals, co-stimulatory cellular signals, and cytokine release, thereby forming the essential bridge between innate and adaptive immune responses. 1

  • DCs are responsible for initiating all antigen-specific immune responses and serve as the master regulators by linking the microbial sensing features of the innate immune system to the specificity of the adaptive response. 3

  • Through their unique T-cell stimulatory capacity, DCs control the initiation of diverse effector functions suitable for eliminating a wide range of pathogens. 4

T Cell Differentiation and Orchestration

  • DCs orchestrate further immune responses by differentiating various subsets of T cells through the use of antigen-specific signals, additional co-stimulatory cellular signals, and release of specific cytokines. 1

  • The innate pattern recognition pathways that trigger DC activation are central for skewing adaptive immune responses, tailoring effector functions to match the nature and localization of infection. 4

  • DCs can induce different T helper cell phenotypes (Th1, Th2, Th17) and regulatory T cells (Tregs) depending on the context of antigen presentation and cytokine milieu. 1

Specialized Functions in Mucosal Immunity

Oral Tolerance Induction

  • In the gut, CD103+ migratory DCs carry antigens from the intestinal mucosa to mesenteric lymph nodes, where they promote regulatory T cell induction, particularly under the influence of TGF-β and retinoic acid derived from vitamin A. 1

  • Oral tolerance depends primarily on finely tuned cross-talk between DCs (innate immunity) and T cells (adaptive immunity), as well as on the integrity of the epithelial barrier in the gut. 1

  • Mucosal DCs play a key role in host defense while maintaining controlled inflammation despite proximity to luminal bacteria, largely regulated by suppressive cytokines TGF-β and IL-10. 1

Bacterial Handling and Antigen Presentation

  • Nod proteins in DCs control autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry, influencing bacterial handling and antigen presentation. 1

  • DCs modulate T-cell responses to luminal antigens, serving as key players in regulating tolerance and immunity induced through the intestine. 1

DC Subsets and Functional Specialization

  • DCs can be broadly classified into conventional DCs (cDC1 and cDC2), plasmacytoid DCs (pDCs), inflammatory DCs, and Langerhans cells, each with unique properties and functions. 5, 2

  • Different DC subsets harbor intrinsic programs enabling them to react to specific pathogens in a subset-dependent manner, thereby orchestrating appropriate T cell immune responses. 5

  • DC subsets express unique and conserved molecules based on their ontogeny, surface phenotype, and specialized functions in different tissue microenvironments. 2

Clinical Implications

Immune Regulation Balance

  • DCs are exceptionally efficient at generating the appropriate type of T cells in response to pathogens while simultaneously guiding the immune system to avoid autoimmune responses to self-antigens, making them paradoxically important in both generating immunity and maintaining tolerance. 3

  • DCs are capable of inducing efficient immune responses but are also crucial for maintaining peripheral tolerance and inhibiting autoimmune reactions. 5

Immunosuppression in Critical Illness

  • Professional antigen-presenting cells, including DCs, reduce expression of the MHC class II molecule HLA-DR after the initial inflammatory response in sepsis or critical illness, which is a hallmark of the immunocompromised state. 6

  • Decreased HLA-DR expression on DCs reflects broader immune dysfunction, including expansion of immunosuppressive cell populations and increased susceptibility to secondary infections. 6

Key Clinical Pitfalls

  • The window of opportunity for DC-mediated tolerance induction is limited to early developmental periods, particularly during neonatal life when the microbiota is being established. 1

  • Abnormal functioning of DCs in an immunologically immature environment (such as in cord blood) can lead to immune dysregulation underlying allergic disorders in infancy. 1

  • DCs must be considered as key players in any therapeutic effort intended to generate vaccines or immunomodulatory therapies, given their central role in controlling immune responses. 3, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dendritic cell subsets and locations.

International review of cell and molecular biology, 2019

Research

Dendritic cells: master regulators of the immune response.

Cancer immunology research, 2013

Research

Determination of T-cell fate by dendritic cells.

Immunology and cell biology, 2008

Research

Transcriptional control of dendritic cell development and functions.

International review of cell and molecular biology, 2019

Guideline

HLA-DR Measurement for Diagnosing Immune Paralysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Distinct features of dendritic cell-based immunotherapy as cancer vaccines.

Clinical and experimental vaccine research, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.